Abstract
I will show you some data that might suggest that antibiotic treatment could fail for the treatment of C. pneumoniae in atherosclerotic lesions. First of all when you summarize the literature there is a striking discrepancy between PCR and immunocytochemistry results. We have summarized here 12 studies of 239 patients in which both PCR and ICC were used on the material of the same patient (Figure 1). What you see if you use a gold standard of either positive in PCR or immunocytochemistry, then PCR alone detects only 50 % of all the patients having C. pneumoniae and immunocytochemistry detects over 80%. Usually PCR is considered a much more sensitive technique than immunocytochemistry. So why is PCR less sensitive than immunocytochemistry?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ossewaarde, J.M. (2000). Why antibiotics against Chlamydia pneumoniae for treatment of atherosclerotic disease could fail. In: L’age-Stehr, J. (eds) Chlamydia pneumoniae and Chronic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57195-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-57195-4_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-41136-9
Online ISBN: 978-3-642-57195-4
eBook Packages: Springer Book Archive